111 related articles for article (PubMed ID: 19825252)
1. Anti-perforin neutralizing antibody reduces myocardial injury in viral myocarditis.
Chun-yan G; Bo H; Hong C; Hong-lei J; Xiu-zhen H
Cardiol Young; 2009 Dec; 19(6):601-7. PubMed ID: 19825252
[TBL] [Abstract][Full Text] [Related]
2. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
3. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
[TBL] [Abstract][Full Text] [Related]
4. The effects of NK4 on viral myocarditis mice.
Shen D; Tang Q; Huang Z; Chen Y; Xiong R; Wu H; Huang J; Feng S; Yan L; Bian Z
Cardiovasc Pathol; 2009; 18(6):323-31. PubMed ID: 19150247
[TBL] [Abstract][Full Text] [Related]
5. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice.
Guan J; Sun X; Liang Y; Dong W; Zhang L; Zhu J; Wang G
J Cardiovasc Pharmacol; 2010 Nov; 56(5):540-7. PubMed ID: 20729751
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.
Yu XH; Li SJ; Chen RZ; Yang YZ; Zhang P
Chin Med J (Engl); 2012 Jan; 125(1):50-5. PubMed ID: 22340465
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
9. Reduction of viral myocarditis in mice lacking perforin.
Koike H; Kanda T; Sumino H; Yokoyama T; Arai M; Motooka M; Suzuki T; Tamura J; Kobayashi I
Res Commun Mol Pathol Pharmacol; 2001; 110(3-4):229-37. PubMed ID: 12760490
[TBL] [Abstract][Full Text] [Related]
10. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
[TBL] [Abstract][Full Text] [Related]
11. The role of apoptosis within the retina of coronavirus-infected mice.
Wang Y; Detrick B; Yu ZX; Zhang J; Chesky L; Hooks JJ
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3011-8. PubMed ID: 10967058
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular cell adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Yazaki Y
J Pathol; 1996 Dec; 180(4):450-4. PubMed ID: 9014868
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
[TBL] [Abstract][Full Text] [Related]
14. Evidence of perforin-mediated cardiac myocyte injury in acute murine myocarditis caused by Coxsackie virus B3.
Seko Y; Shinkai Y; Kawasaki A; Yagita H; Okumura K; Yazaki Y
J Pathol; 1993 May; 170(1):53-8. PubMed ID: 8392106
[TBL] [Abstract][Full Text] [Related]
15. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
16. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
17. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
Khatib R; Reyes MP; Khatib G; Giraldo A
Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
[TBL] [Abstract][Full Text] [Related]
18. Murine natural killer cells limit coxsackievirus B3 replication.
Godeny EK; Gauntt CJ
J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
20. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis.
Kytö V; Lapatto R; Lakkisto P; Saraste A; Voipio-Pulkki LM; Vuorinen T; Pulkki K
Eur J Clin Invest; 2004 Mar; 34(3):167-75. PubMed ID: 15025674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
